Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched ...
Recursion Pharmaceuticals has raised $60 million to step up its artificial intelligence-enabled drug discovery activities. The series B equips Recursion to move beyond its initial focus on repurposing ...
Recursion Pharmaceuticals has secured $239 million in new venture capital financing, plus a long-term collaboration deal with Bayer to help boost its pipeline in fibrotic diseases of the lung, heart, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results